Stelvio Therapeutics

Stelvio Therapeutics is located in San Diego, United States on 3210 Merryfield Row. Stelvio Therapeutics is rated 3 out of 5 in the category biotechnology in United States. Stelvio Therapeutics is a biotechnology company that focuses on developing a pipeline of alternative treatments for malignant glioblastoma multiforme (GBM), the most common and lethal brain tumor. Instead of trying to kill tumor cells, Stelvio Therapeutics is developing treatments that will induce differentiation of tumor propagating cells into non-tumorigenic cells - a potent new strategy to fight GBM that could ultimately lead to more viable alternatives for patients.